Zobrazeno 1 - 10
of 145
pro vyhledávání: '"Shohei Mizuno"'
Autor:
Shohei Mizuno, Akiyoshi Takami, Koji Kawamura, Kaito Harada, Masuko Masayoshi, Shingo Yano, Ayumu Ito, Yukiyasu Ozawa, Fumihiko Ouchi, Takashi Ashida, Yuichiro Nawa, Tatsuo Ichinohe, Takahiro Fukuda, Yoshiko Atsuta, Masamitsu Yanada
Publikováno v:
eJHaem, Vol 5, Iss 2, Pp 369-378 (2024)
Abstract BCR::ABL1 fusion is found in
Externí odkaz:
https://doaj.org/article/a4f3734c09f64c24bc3a62ed96037de3
Autor:
Sivasundaram Karnan, Ichiro Hanamura, Akinobu Ota, Lam Quang Vu, Kaori Uchino, Tomohiro Horio, Satsuki Murakami, Shohei Mizuno, Md Lutfur Rahman, Md Wahiduzzaman, Muhammad Nazmul Hasan, Mrityunjoy Biswas, Toshinori Hyodo, Hideaki Ito, Atsushi Suzuki, Hiroyuki Konishi, Shinobu Tsuzuki, Yoshitaka Hosokawa, Akiyoshi Takami
Publikováno v:
Cell Death Discovery, Vol 10, Iss 1, Pp 1-11 (2024)
Abstract 5′ adenosine monophosphate–activated protein kinase–related kinase 5 (ARK5) is involved in mitochondrial ATP production and associated with poor prognosis of multiple myeloma (MM). However, the molecular mechanisms of ARK5 in MM remain
Externí odkaz:
https://doaj.org/article/c8c4f6b7fa1a404da2825b786d04fd7b
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 18, p 10160 (2024)
Mucosal-associated invariant T cells (MAIT cells) are a subset of T cells with innate, effector-like properties that play an essential role in the immune response to microbial infections. In humans, MAIT cells are detectable in the blood, liver, and
Externí odkaz:
https://doaj.org/article/2dae4967851f4b8b81c95843dc5080b2
Autor:
Hideshige Seki, Shohei Mizuno, Sakura Saigusa, Yukie Sugita, Yusuke Iida, Saki Shinohara, Kaori Uchino, Tomohiro Horio, Ichiro Hanamura, Akiyoshi Takami
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 15, p 4340 (2024)
Background: Primary bladder lymphoma is generally regarded as having a favorable prognosis due to the predominance of low-grade lymphomas confined to the bladder. However, our investigation reveals that cases with extravesical extension, predominantl
Externí odkaz:
https://doaj.org/article/3c16b3fa70ee4ee893c4fbb9ef5100b0
Autor:
Kotaro Shide, Katsuto Takenaka, Akira Kitanaka, Akihiko Numata, Takuro Kameda, Takuji Yamauchi, Atsushi Inagaki, Shohei Mizuno, Akiyoshi Takami, Shinichi Ito, Masao Hagihara, Kensuke Usuki, Takaaki Maekawa, Kazutaka Sunami, Yasunori Ueda, Miyuki Tsutsui, Miki Ando, Norio Komatsu, Keiya Ozawa, Mineo Kurokawa, Shunya Arai, Kinuko Mitani, Koichi Akashi, Kazuya Shimoda
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-4 (2023)
Externí odkaz:
https://doaj.org/article/6eb907e16c1c4b6ea39334e13b0b69d5
Autor:
Hiroki Mizumaki, Ken Ishiyama, Jun Aoki, Jinichi Mori, Shohei Mizuno, Noriko Doki, Takahiro Fukuda, Naoyuki Uchida, Masahito Onizuka, Masatsugu Tanaka, Yuta Katayama, Yukiyasu Ozawa, Kazuhiro Ikegame, Satoru Takada, Toshiro Kawakita, Nobuyuki Aotsuka, Yoshiko Atsuta, Masamitsu Yanada
Publikováno v:
eJHaem, Vol 4, Iss 1, Pp 251-257 (2023)
Abstract The prognosis of acute myeloid leukemia (AML) patients with der(1;7)(q10;p10) who underwent allogeneic hematopoietic stem cell transplantation (allo‐SCT) is unclear due to its rarity. We retrospectively analyzed 151 AML patients with der(1
Externí odkaz:
https://doaj.org/article/f8c29b89765d4b6d9344c3c0455cf547
Autor:
Hiroyuki Takamatsu, Tomohiro Matsuda, Shohei Mizuno, Tsutomu Takahashi, Shin-ichi Fuchida, Ichiro Hanamura, Keisuke Kataoka, Nobuhiro Tsukada, Morio Matsumoto, Akira Hangaishi, Noriko Doki, Naoyuki Uchida, Masashi Sawa, Yumiko Maruyama, Shingo Kurahashi, Koji Nagafuji, Yoriko Harazaki, Shinichi Kako, Shinsuke Iida, Tatsuo Ichinohe, Yoshinobu Kanda, Yoshiko Atsuta, Kazutaka Sunami, Multiple Myeloma Working Group in the Japanese Society for Transplantation and Cellular Therapy
Publikováno v:
Haematologica, Vol 108, Iss 12 (2023)
The incidence of second primary malignancies (SPM) in long-term survivors of multiple myeloma (MM) is increasing because of increased life expectancy. We retrospectively analyzed the risk factors for SPM in patients with MM after autologous stem cell
Externí odkaz:
https://doaj.org/article/4c8e66092f1f49feb08e8673e19eb376
Autor:
Takaaki Konuma, Shohei Mizuno, Tadakazu Kondo, Yasuyuki Arai, Naoyuki Uchida, Satoshi Takahashi, Masatsugu Tanaka, Takuro Kuriyama, Shigesaburo Miyakoshi, Makoto Onizuka, Shuichi Ota, Yasuhiro Sugio, Yasushi Kouzai, Toshiro Kawakita, Hikaru Kobayashi, Yukiyasu Ozawa, Takafumi Kimura, Tatsuo Ichinohe, Yoshiko Atsuta, Masamitsu Yanada, for the Adult Acute Myeloid Leukemia Working Group of the Japanese Society for Transplantation and Cellular Therapy
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 5, Pp 1-12 (2022)
Abstract Unrelated cord blood transplantation (CBT) is an alternative curative option for adult patients with acute myeloid leukemia (AML) who need allogeneic hematopoietic cell transplantation (HCT) but lack an HLA-matched related or unrelated donor
Externí odkaz:
https://doaj.org/article/660bfbb942e140e3b2a59f19b7d5883d
Autor:
Kaori Uchino, Lam Vu Quang, Megumi Enomoto, Yuta Nakano, Saki Yamada, Saori Matsumura, Jo Kanasugi, Soichi Takasugi, Ayano Nakamura, Tomohiro Horio, Satsuki Murakami, Mineaki Goto, Shohei Mizuno, Hidesuke Yamamoto, Masaya Watarai, Ichiro Hanamura, Akiyoshi Takami
Publikováno v:
eJHaem, Vol 2, Iss 4, Pp 729-737 (2021)
Abstract Introduction Due to an increased incidence of copper deficiency, we investigated adult patients who had low serum levels of copper with cytopenia at our hospital from March 2014 to March 2021. Methods We retrospectively reviewed the clinical
Externí odkaz:
https://doaj.org/article/bd0001a5b49e4f27833028bc9a35b610
Autor:
Shuhei Kurosawa, Shohei Mizuno, Yasuyuki Arai, Masayoshi Masuko, Junya Kanda, Kentaro Kohno, Daishi Onai, Takahiro Fukuda, Yukiyasu Ozawa, Yuta Katayama, Masatsugu Tanaka, Kazuhiro Ikegame, Naoyuki Uchida, Tetsuya Eto, Shuichi Ota, Junji Tanaka, Tatsuo Ichinohe, Yoshiko Atsuta, Masamitsu Yanada
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 9, Pp 1-8 (2021)
Abstract The present study evaluated outcomes and prognostic factors in adult patients with acute myeloid leukemia (AML) after syngeneic hematopoietic stem cell transplantation (HSCT). Among patients in first complete remission (CR1), outcomes of syn
Externí odkaz:
https://doaj.org/article/4536ccadd7614397adced0e486e49c49